Sen. Paul Plans to Amend Senate Law to Legalize Medical Marijuana in Approved States

0
79

Sen. Paul Plans to Amend Senate Law to Legalize Medical Marijuana in Approved StatesKentucky Senator Rand Paul tabled a proposal in the senate to amend federal laws to protect states that have enacted medical marijuana laws, along with physicians and patients in such states from prosecution.

The Amendment 3630 seeks to permit states to “enact and implement laws that authorize the use, distribution, possession, or cultivation of marijuana for medical use without fearing prosecution under federal law”. The amendment will also protect doctors and patients in such state from prosecution for breaking federal laws on marijuana, reported Huffington Post.

So far, 33 states have approved laws that touch on medical marijuana, with 23 of them and the District of Columbia having approved it for medical purposes. The other 10 states have legalized the use of CBD, a non-psychoactive compound found in marijuana that can be used to treat epilepsy, for research or limited medical use.

**relatedarticle**

Currently, the federal government classified marijuana as a Schedule I substance that has no currently accepted medical purpose.

Paul presented a Senate amendment to the U.S. Justice Department budget bill, restricting federal prosecutors and DEA agents from using the funds allocated to the department to harass medical marijuana providers and patients in states that have decriminalized its use.

However, owing to the Senate’s partisan impasse, it looks less likely that Paul’s amendment may obtain a vote. Paul’s office plans to use another legislation that may not match with the amendment, though it will be in the same faith and spirit.

A similar adaptation of the amendment, which is co-sponsored by representatives Sam Farr (D-Calif) and Dana Rohrbacher (R-Calif), confounded even pro-medical marijuana activists when it was approved by the House in May. To register for a free 2-week subscription to ForexMinute Premium Plan, visit www.forexminute.com/newsletter.

To contact the reporter of this story; Jonathan Millet at john@forexminute.com